Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Dexketoprofen

Next Previous
X
Search
Drug Profile

Dexketoprofen

Alternative Names: Arveles; D 1158; Desketo; Dexketoprofen trometamol; Dexketoprofen tromethamine; Dextroketoprofen; Enangel; Enantyum; Keral; Ketesse; LM 1158; Nosatel; Quiralam; Quirgel; S-ketoprofen; Stadium; Sympal; Viaxal

Latest Information Update: 06 Jan 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Menarini
  • Developer Berlin Chemie; Celltech Group; Istituto Lusofarmaco; Malesci; Menarini
  • Class Nonsteroidal anti-inflammatories; Phenylpropionates; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Prostaglandin synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Inflammation; Musculoskeletal pain; Pain

Most Recent Events

  • 01 May 2014 Menarini completes a phase I bioavailability trial in volunteers in United Kingdom (NCT02209454)
  • 01 Apr 2014 Menarini initiates a phase I bioavailability trial in volunteers in United Kingdom (NCT02209454)
  • 23 Jan 2007 Menarini completes a phase III trial for Pain in Spain (IV) in January 2007 (EudraCT2004-001789-42)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top